TIM3 expression on tumor cells predicts response to anti-PD-1 therapy for renal cancer

This study aimed to identify novel prognostic biomarker for advanced renal cell carcinoma (RCC) patients treated with anti-PD-1 therapy, using quantitative multi-immunofluorescence (IF) analysis of tumor immunity. Twenty-five consecutive patients who had metastatic or unresectable RCC treated with a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Transl Oncol
Päätekijät: Kato, Renpei, Jinnouchi, Noriaki, Tuyukubo, Takashi, Ikarashi, Daiki, Matsuura, Tomohiko, Maekawa, Shigekatsu, Kato, Yoichiro, Kanehira, Mitsugu, Takata, Ryo, Ishida, Kazuyuki, Obara, Wataru
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Neoplasia Press 2020
Aiheet:
Original article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7586238/
https://ncbi.nlm.nih.gov/pubmed/33129110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2020.100918
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia